185 related articles for article (PubMed ID: 3523507)
1. Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.
Sjöqvist F; Bertilsson L
Prog Clin Biol Res; 1986; 214():169-88. PubMed ID: 3523507
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of antidepressant drugs: pharmacogenetics.
Sjöqvist F; Bertilsson L
Adv Biochem Psychopharmacol; 1984; 39():359-72. PubMed ID: 6380229
[TBL] [Abstract][Full Text] [Related]
3. Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations.
von Bahr C; Birgersson C; Morgan ET; Eriksson O; Göransson M; Spina E; Woodhouse K
Xenobiotica; 1986 May; 16(5):391-400. PubMed ID: 3739365
[TBL] [Abstract][Full Text] [Related]
4. Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.
Bertilsson L; Aberg-Wistedt A; Gustafsson LL; Nordin C
Ther Drug Monit; 1985; 7(4):478-80. PubMed ID: 4082245
[No Abstract] [Full Text] [Related]
5. [Genetic polymorphism and metabolism of tricyclic antidepressants].
Samyn B
Encephale; 1992; 18(6):661-4. PubMed ID: 1342665
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetics of antidepressant metabolism. Value of the debrisoquin test].
Baumann P
Encephale; 1986; 12(4):143-8. PubMed ID: 3792273
[TBL] [Abstract][Full Text] [Related]
7. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
[TBL] [Abstract][Full Text] [Related]
8. E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
Mellström B; Bertilsson L; Säwe J; Schulz HU; Sjöqvist F
Clin Pharmacol Ther; 1981 Aug; 30(2):189-93. PubMed ID: 7249504
[TBL] [Abstract][Full Text] [Related]
9. [Knowledge about metabolic capacity is important in drug therapy].
Alván G; Dahl ML
Lakartidningen; 1992 Feb; 89(6):382, 387-90. PubMed ID: 1738265
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between amitriptyline metabolism and polymorphic debrisoquine hydroxylation in native Chinese volunteers].
Zhang XH; Yu P; Gu NF; Yin JL; Jiang WD
Yao Xue Xue Bao; 1993; 28(2):85-91. PubMed ID: 8328289
[TBL] [Abstract][Full Text] [Related]
12. Amitriptyline metabolism: relationship to polymorphic debrisoquine hydroxylation.
Mellström B; Bertilsson L; Lou YC; Säwe J; Sjöqvist F
Clin Pharmacol Ther; 1983 Oct; 34(4):516-20. PubMed ID: 6617075
[TBL] [Abstract][Full Text] [Related]
13. Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin.
Baumann P; Jonzier-Perey M; Koeb L; Küpfer A; Tinguely D; Schöpf J
Int Clin Psychopharmacol; 1986 Apr; 1(2):102-12. PubMed ID: 3571939
[TBL] [Abstract][Full Text] [Related]
14. Plasma level monitoring of antidepressants: theoretical basis and clinical application.
Gram LF; Kragh-Sørensen P; Kristensen CB; Møller M; Pedersen OL; Thayssen P
Adv Biochem Psychopharmacol; 1984; 39():399-411. PubMed ID: 6380231
[TBL] [Abstract][Full Text] [Related]
15. Tricyclic antidepressants: a simplified approach for the routine clinical monitoring of parent drug and metabolites in plasma using HPLC.
Dixon R; Marin D
Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):537-45. PubMed ID: 7330455
[TBL] [Abstract][Full Text] [Related]
16. Desmethylimipramine overdose: nonlinear kinetics in a slow hydroxylator.
Spina E; Henthorn TK; Eleborg L; Nordin C; Säwe J
Ther Drug Monit; 1985; 7(2):239-41. PubMed ID: 4024220
[TBL] [Abstract][Full Text] [Related]
17. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
[TBL] [Abstract][Full Text] [Related]
18. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
Lydiard RB
J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
[TBL] [Abstract][Full Text] [Related]
19. Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity.
Potter WZ; Calil HM; Manian AA; Zavadil AP; Goodwin FK
Biol Psychiatry; 1979 Aug; 14(4):601-13. PubMed ID: 486616
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
Spina E; Birgersson C; von Bahr C; Ericsson O; Mellström B; Steiner E; Sjöqvist F
Clin Pharmacol Ther; 1984 Nov; 36(5):677-82. PubMed ID: 6488689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
